# Vitalant – FDA Inspection, Jun 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/6fc09fbd-6d45-4196-9c07-ba0a626ea5e6
Source feed: FDA_Inspections

> FDA inspection 1242507 of Vitalant, June 27, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242507
- Company Name: Vitalant
- Inspection Date: 2024-06-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1090371 - 2019-05-15](https://www.keypedia.com/records/fda_inspections/vitalant/46df109c-0c64-457a-897e-19c0c96ee5b8)
- FDA Inspection 1021901 - 2017-08-15
- FDA Inspection 918326 - 2015-03-06
- FDA Inspection 844627 - 2013-08-15
- FDA Inspection 749564 - 2011-10-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/vitalant/9164ea0a-e239-464b-ae59-3c1488db7a57

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
